QVCCQ — QVC INC

OTC · Consumer Discretionary · Internet & Direct Marketing Retail · CIK 1254699 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 2,134,000,000 760,000,000 163,000,000 53,000,000 9,889,000,000 6,520,000,000
Dec 2023 2,194,000,000 770,000,000 154,000,000 51,000,000 11,720,000,000 307,000,000 7,383,000,000
Dec 2022 2,217,000,000 691,000,000 -2,084,000,000 -2,226,000,000 12,404,000,000 357,000,000 7,832,000,000
Dec 2021 2,512,000,000 895,000,000 316,000,000 145,000,000 16,141,000,000 510,000,000 8,420,000,000

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2023 9,887,000,000 -1,399,000,000 -1,867,000,000 11,720,000,000 7,383,000,000
Dec 2022 11,354,000,000 1,507,000,000 787,000,000 12,404,000,000 7,832,000,000
Dec 2021 11,472,000,000 1,567,000,000 844,000,000 16,141,000,000 8,420,000,000
Dec 2020 10,986,000,000 1,327,000,000 767,000,000 16,558,000,000 8,423,000,000
Dec 2019 11,282,000,000 1,512,000,000 882,000,000 14,927,000,000 8,123,000,000
Dec 2018 2,602,000,000 356,000,000 201,000,000 14,856,000,000 8,027,000,000
Dec 2017 1,965,000,000 271,000,000 124,000,000 14,319,000,000 8,523,000,000
Dec 2016 2,013,000,000 261,000,000 125,000,000 11,545,000,000 7,650,000,000
Dec 2015 1,938,000,000 246,000,000 115,000,000 12,058,000,000 7,940,000,000
Dec 2014 1,986,000,000 260,000,000 113,000,000 12,225,000,000 7,179,000,000

TTM Snapshot

Revenues TTM
$9,057,000,000
NetIncome TTM
$-1,977,000,000
OpCashFlow TTM
$0
Assets (Latest)
$9,889,000,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
AMZN AMAZON COM INC $2.57T $238.55
CPNG Coupang, Inc. $27.54B $16.82
CDW CDW Corp $16.89B $132.19
W Wayfair Inc. $8.61B $77.59
VIPS Vipshop Holdings Ltd $5.60B $13.92

Recent Insider Activity

No insider activity indexed for this ticker.